Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
2.
Cir Esp (Engl Ed) ; 101(3): 180-186, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36152962

RESUMO

INTRODUCTION: Anal intraepithelial neoplasia (AIN) is a premalignant lesion of anal squamous cell carcinoma. HIV-positive males who have sex with males, are the most affected at-risk population. Cytology and anuscopy are the best accepted methods for its diagnosis, although it is controversial which patients should complete it with a biopsy. Neither which patients should undergo treatment nor which is the best treatment is not well established. With this study, we would like to present our experience in the diagnostic-therapeutic management of AIN in the short term. METHODS: Retrospective observational study of patients at risk of AIN with altered anal cytology who underwent high-resolution anuscopy with biopsy. After histological confirmation of dysplasia, they started treatment with trichloroacetic acid. Its effectiveness was verified by subsequent cytology. The demographic variables of the sample and the results of both diagnostic and treatment tests were analyzed. RESULTS: The majority were HIV-positive males (104/115) and 50% had sexual relations with other men. We included 115 patients with altered anal cytology, of whom 92% had dysplasia on biopsy. 97% with atypia of uncertain significance on cytology had histological dysplasia. Cytology normalized after treatment in 60% of patients. CONCLUSION: Early detection of AIN should be routinely considered in known at-risk populations. Any cytological abnormality should be biopsied. Tricholoroacetic acid can be an effective treatment achieving a high percentage of regression, although currently, the information we have is of low level of evidence.


Assuntos
Neoplasias do Ânus , Carcinoma in Situ , Infecções por HIV , Infecções por Papillomavirus , Minorias Sexuais e de Gênero , Masculino , Humanos , Homossexualidade Masculina , Infecções por Papillomavirus/diagnóstico , Infecções por Papillomavirus/epidemiologia , Neoplasias do Ânus/patologia , Carcinoma in Situ/patologia
3.
Rev. chil. obstet. ginecol. (En línea) ; 86(4): 397-402, ago. 2021. ilus, tab
Artigo em Espanhol | LILACS | ID: biblio-1388676

RESUMO

ANTECEDENTES: El hematoma espontáneo del cordón umbilical es una complicación rara del embarazo que representa una causa grave de morbilidad y mortalidad fetal. Se han descrito numerosos factores de riesgo, pero aún se desconoce su etiología exacta. CASO CLÍNICO: Mujer de 28 años, en su octava gestación, que consultó en urgencias por disminución de los movimientos fetales de varias horas de evolución tras una caída accidental traumática. La monitorización fetal mostró un patrón cardiotocográfico no tranquilizador, con disminución de la variabilidad y sin aceleraciones. Se realizó una cesárea urgente, sin complicaciones, con el nacimiento de un varón vivo de 4560 g, con Apgar 8/10/10 y pH de sangre de cordón umbilical 7.08, que precisó ingreso en la unidad de neonatología por hallazgo de un soplo cardíaco. Tras el alumbramiento se objetivó una gran colección hemática en el cordón umbilical. MÉTODO: Se aplicó una estrategia de búsqueda sistemática en Medline, PubMed y Cochrane de todos los artículos en inglés y español que tuvieran como palabras clave "Umbilical", "Cordón" y "Hematoma". RESULTADOS: Se encontraron 13 publicaciones de 15 casos de hematoma del cordón umbilical en los años 2008-2020. Se realizó una revisión sistemática de los informes de casos descritos en los últimos 12 años en la literatura para evaluar la epidemiología, los factores predisponentes, los resultados potenciales, el diagnóstico prenatal y el manejo clínico. CONCLUSIONES: Debido a la rareza de esta afección, se deben informar todos los casos nuevos de hematoma del cordón umbilical para mejorar el conocimiento de los factores predisponentes, el diagnóstico prenatal y el manejo clínico.


BACKGROUND: Spontaneous umbilical cord hematoma is a rare complication of pregnancy which represents a serious cause of fetal morbidity and mortality. There are many risk factors, but the exact etiology is still unknown. CASE REPORT: 28-year-old woman, eighth gestation, who consulted due to decreased fetal movements of several hours of evolution after traumatic accidental fall. Fetal monitoring showed a non-reassuring cardiotocographic pattern, with decreased fetal variability, without accelerations. An emergency cesarean section was performed without complications, with the birth of a living male weighing 4560 grams, with an 8/10/10 Apgar test, and an arterial pH of the umbilical cord 7.08, which required admission to the neonatology unit. After delivery, a large blood collection was observed in the umbilical cord. METHOD: A systematic search strategy was applied to several electronic bibliographic databases: Medline, PubMed and Cochrane. Key words used were "Umbilical", "Cord", "Hematoma". RESULTS: 13 publications of 15 cases of umbilical cord hematoma were reported in the years 2008-2020. A systematic review of the reports of cases, described in the last twelve years in the literature was carried out to evaluate the epidemiology, predisposing factors, potential results, prenatal diagnosis and clinical management of this phenomenon. CONCLUSIONS: Due to the rarity of this condition, every new case of umbilical cord hematoma should be reported in order to improve the knowledge of predisposing factors, prenatal diagnosis, and clinical management.


Assuntos
Humanos , Feminino , Gravidez , Recém-Nascido , Adulto , Cordão Umbilical/patologia , Hematoma/diagnóstico , Hemorragia
4.
Rev. méd. Chile ; 149(5): 724-732, mayo 2021. ilus, tab
Artigo em Espanhol | LILACS | ID: biblio-1389509

RESUMO

Background: Vitamin K antagonists such as acenocoumarol and warfarin are usually indicated for the treatment of Atrial Fibrillation (AF). The Therapeutic Range Time (TRT) is a quality of treatment indicator. Values greater than 65% are associated with significantly lower stroke and bleeding rates. Proper pharmaceutical care improves TRT. Aim: To evaluate the impact of pharmaceutical care in patients with AF treated with acenocoumarol. Material and Methods: We studied 41 patients using acenocoumarol for AF aged 71 ± 11 years (43% women). They received pharmaceutical counseling during 12 weeks. TRT was calculated retrospectively for the year before counseling and prospectively during the intervention period. Results: After receiving pharmaceutical counseling TRT improved from 29% at baseline to 46% at the end of the intervention (p < 0.01). After pharmaceutical care, the adherence of patients to drug treatment improved from 27% at baseline to 85% at the end of the study. The user satisfaction survey of the pharmaceutical care received showed a high degree of patient satisfaction. Conclusions: Pharmaceutical care in patients with oral anticoagulant treatment improves TRT of anticoagulation. It is accepted and positively evaluated by patients.


Assuntos
Humanos , Masculino , Feminino , Fibrilação Atrial/complicações , Fibrilação Atrial/tratamento farmacológico , Preparações Farmacêuticas , Acidente Vascular Cerebral/prevenção & controle , Acidente Vascular Cerebral/tratamento farmacológico , Administração Oral , Estudos Retrospectivos , Aconselhamento , Anticoagulantes/uso terapêutico
6.
Rev. méd. Chile ; 148(9)sept. 2020.
Artigo em Espanhol | LILACS | ID: biblio-1389323

RESUMO

Background: Vitamin K antagonist medications (VKA) are essential for the prevention of thromboembolic events, but their effectiveness is influenced by multiple factors, such as the type of medication chosen. Aim: To evaluate the efficacy in anticoagulant control of the bioequivalent and non-bioequivalent drugs of acenocoumarol compared to the reference drug. To evaluate the efficacy of warfarin bioequivalents available in Chile. To contrast the overall anticoagulant control efficacy between acenocoumarol and warfarin. Material and Methods: The results of 69333 outpatient oral anticoagulation controls were analyzed. Patient were separated in groups according to the drug that they used. Subsequently, the proportions of controls outside the range for each of acenocoumarol and warfarin bioequivalent drugs were compared. Acenocoumarol non-bioequivalent drugs were also compared with the reference drug. Acenocoumarol was compared with warfarin. Results: Acenocoumarol bioequivalent drugs and the reference drug had a similar proportion of controls outside the range (Odds ratios (OR) 0.812; 0.969; 0.974 and 0.963). Non-bioequivalent drugs had a higher proportion than the reference drug (OR 1.561 and 2.037). Both warfarin brands have a similar proportion of controls outside of the range (OR 1.050). Acenocoumarol compared to warfarin had a significant higher proportion of controls outside the range (OR 1.191). Conclusions: The pharmacological presentation of vitamin K antagonists could influence anticoagulant control. Therefore, it is not prudent to switch these presentations frequently.


Assuntos
Humanos , Tromboembolia , Vitamina K , Anticoagulantes , Tromboembolia/prevenção & controle , Vitamina K/antagonistas & inibidores , Chile , Administração Oral , Acenocumarol , Anticoagulantes/uso terapêutico
7.
Cir Esp (Engl Ed) ; 98(7): 395-402, 2020.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32115188

RESUMO

INTRODUCTION: Single parathyroid adenomas are the most common cause of primary hyperparathyroidism (PHP) in our population. Parathyroidectomy is still the only potentially curative treatment and requires preoperative localization imaging studies to perform selective surgery. In patients with negative results on conventional tests, PET/CT has demonstrated higher sensitivity rates. METHODS: A prospective cohort study was designed, including 34 patients diagnosed with PHP between 2017 and 2019, candidates for surgery with negative preoperative localization tests with scintigraphy and MIBI SPECT/CT. All patients underwent PET/CT with 18F-Fluorocholine. The clinical, biochemical and postoperative outcome results were compared with a control group of 30 patients with positive standard tests. RESULTS: Hyperfunctional parathyroid tissue was detected in 85% of the patients that had undergone choline PET/CT. The selective resection of the adenoma identified in these patients achieved curative criteria in 87% of the cases without undergoing bilateral cervical surgical exploration. The preoperative levels of PTH, calcemia and gland weight were significantly lower in this group compared to the control group. No differences were identified in cure criteria or approach between the 2groups. CONCLUSION: In our study, choline PET/CT showed higher detection rates compared to the gold standard. The increase provides the opportunity to perform unilateral selected adenoma resection, especially in patients with smaller adenomas associated with lower calcemia and PTH levels and patients with previous cervical surgery.


Assuntos
Colina/análogos & derivados , Hiperparatireoidismo Primário/patologia , Neoplasias das Paratireoides/diagnóstico por imagem , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada/métodos , Idoso , Cálcio/sangue , Estudos de Casos e Controles , Colina/administração & dosagem , Colina/química , Feminino , Humanos , Hiperparatireoidismo Primário/diagnóstico , Masculino , Pessoa de Meia-Idade , Neoplasia Endócrina Múltipla/diagnóstico , Neoplasia Endócrina Múltipla/patologia , Neoplasias das Paratireoides/cirurgia , Paratireoidectomia/métodos , Fosfatos/sangue , Período Pós-Operatório , Período Pré-Operatório , Estudos Prospectivos , Cintilografia/normas , Sensibilidade e Especificidade
8.
Rev. méd. Chile ; 147(10): 1273-1282, oct. 2019. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1058594

RESUMO

Background: INR is used to monitor the treatment with vitamin K antagonists. A strategy to reduce waiting times for sampling is to measure INR in a capillary sample using a portable point of care (POC) type coagulometer. Aim: To evaluate the correlation of CoaguChek Pro II™, Xprecia™ and microINR™ with venous INR measured at the clinical laboratory and their ease of use. Materials and Methods: Patients provided capillary and venous blood samples for parallel tests comparing Xprecia™ Stride with CoaguChek Pro II™ and with venous INR, microINR™ with CoaguChek Pro IITM and with venous INR. The devices' ease of use was assessed surveying the sampling staff. Results: The three tested devices had good correlation coefficients with venous INR: CoaguChek Pro IITM 0.953 and 0.962; Xprecia™ of 0.912 and microINR™ of 0.932. The correlation coefficient of Xprecia™ with CoaguChek Pro IITM was 0.937 and microINR™ with CoaguChek Pro IITM was 0.976. Conclusions: CoaguChek Pro IITM, Xprecia™ and microINR™ results had a good correlation coefficient with INR measured at the laboratory. Our results indicate that, in the hands of trained users, POC-type coagulometers are reliable and acceptable for routine use in anticoagulant treatment control.


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Sistemas Automatizados de Assistência Junto ao Leito/normas , Coeficiente Internacional Normatizado/instrumentação , Padrões de Referência , Capilares , Tromboplastina/uso terapêutico , Chile , Reprodutibilidade dos Testes , Monitoramento de Medicamentos/instrumentação , Monitoramento de Medicamentos/normas , Coeficiente Internacional Normatizado/normas , Anticoagulantes/uso terapêutico
9.
Rev. méd. Chile ; 144(4): 434-441, abr. 2016. ilus, graf, tab
Artigo em Espanhol | LILACS | ID: lil-787114

RESUMO

Background: Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) reduces disability in patients with ischemic stroke. However, its implementation in Chilean public general hospitals has been slow and faces some difficulties. Aim: To analyze the results of an intravenous thrombolysis protocol implementation in a public general hospital. Material and Methods: During a lapse of 28 months a standardized protocol for intravenous thrombolysis implemented in the emergency room of a public hospital, was prospectively evaluated. Fifty four patients with ischemic stroke were treated and assessed three months later as outpatients. Results: At three months of follow-up, 66.4% of patients subjected to thrombolysis had a favorable evolution, defined as having 0 to 1 points in the modified Rankin scale. Intracerebral hemorrhage rate was 11.1%, including 5.5% of symptomatic intracerebral hemorrhage. Four percent of patients had systemic bleeding complications after thrombolysis. The mortality rate was 14.8%. Conclusions: The success rates, mortality, and complications rate were comparable to the results obtained in international studies, despite of the absence of a stroke unit to manage stroke and its complications.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Ativadores de Plasminogênio/uso terapêutico , Terapia Trombolítica/métodos , Isquemia Encefálica/tratamento farmacológico , Acidente Vascular Cerebral/tratamento farmacológico , Fibrinolíticos/uso terapêutico , Fatores de Tempo , Índice de Gravidade de Doença , Infusões Intravenosas , Encéfalo/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Hemorragia Cerebral/etiologia , Hemorragia Cerebral/prevenção & controle , Isquemia Encefálica/complicações , Estudos Prospectivos , Reprodutibilidade dos Testes , Resultado do Tratamento , Progressão da Doença , Acidente Vascular Cerebral/complicações , Hospitais Públicos
10.
Rev. chil. cardiol ; 35(1): 25-31, 2016. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-782639

RESUMO

Antecedentes: En el año 2014 se inició Telemedicina desde el Policlinico de Tratamiento Anticoagulante oral del Hospital San Juan de Dios y el Hospital de Curacaví, evitando así el traslado de pacientes a Santiago para el control con el médico especialista. Métodos: Se utilizó licencia de video conferencia en el Hospital San Juan de Dios, dispositivo móvil, equipo de INR capilar y stock de Acenocumarol en el Hospital de Curacaví. Resultados: En total se han realizado 2.174 consultas vía Telemedicina (junio 2014 a diciembre 2015). Esta estrategia ha sido bien evaluada por los pacientes. La mejora en la calidad del tratamiento ha sido evidente: 58,3% de los pacientes del Hospital de Curacaví se encuentran en rango terapéutico, superior al 50,8% de los pacientes del Hospital San Juan de Dios (p < 0,05). En cuanto al Tiempo en Rango Terapéutico (TTR) 50,6% de los pacientes del Hospital de Curacaví se encuentran en rango versus 46,2% de los pacientes del Hospital San Juan de Dios (p< 0,05). Conclusiones: La Telemedicina utilizada por equipos comprometidos es capaz de mantener indicadores de calidad de la atención que la validan como herramienta de atención clínica a distancia. La Telemedicina, en cuanto es una herramienta que acerca el especialista a comunidades alejadas de centros hospitalarios complejos, es valorada y muy bien calificada por los usuarios.


Background: Starting in 2014 telemedicine has been used to control oral anticoagulant treatment (OAT) in patients attending a peripheral hospital (Curacaví), in connection with Hospital San Juan de Dios, based in Santiago. Methods: A license for video conference was available to communicate both hospitals. Capillary INR and medications were available at Curacaví Hospital. Results: Between June 2014 and December 2015, 2174 indications for OAT have been made through tele-medicine. Different estimates of quality of care and user satisfaction have been rated > 6.7 (1-7 scale). Percent of INR measurements in therapeutic range was 58.3% in Curacavi and 50.8% at Hospital San Juan de Dios (p<0.05) and time in therapeutic range was 50.6% vs 42.6%, respectively (p<0.05) Conclusion: Tele-medicine allowed a close relationship between remote medical facilities and a complex medical center and was fully validated as a means of controlling OAT with a high degree of acceptance by patients.


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Monitoramento de Medicamentos , Telemedicina/métodos , Anticoagulantes/administração & dosagem , Fatores de Tempo , Capilares , Administração Oral , Inquéritos e Questionários , Satisfação do Paciente , Coeficiente Internacional Normatizado
11.
Rev. méd. Chile ; 143(11): 1369-1376, nov. 2015. graf, tab
Artigo em Espanhol | LILACS | ID: lil-771725

RESUMO

Background: The dose of oral anticoagulants (OAC) shows great variability among patients. Pharmacogenetic studies have shown that common variants in genes CYP2C9 (*2 and *3) and VKORC1 (-1639G>A) are associated with lower requirements of OAC. Aim: To study the association between average maintenance doses of oral anticoagulant therapy required to maintain a stable INR and CYP2C9 and VKORC1 gene variants in Chilean adults. Material and Methods: Prospective study of patients on anticoagulant treatment and with a stable international normalized ratio (INR) for prothrombin time for at least three months. Patients were classified as having high or low acenocoumarol or warfarin requirements. Peripheral blood DNA genotyping was performed by polymerase chain reaction and restriction fragment polymorphism or sequencing and electrophoresis. Results: The study included 185 patients, 125 on acenocoumarol and 60 on warfarin. Patients with VKORC1-1639A allele were more likely to require lower doses of both drugs than patients with the G allele (Odds ratio [OR] for acenocoumarol 9.06, and OR for warfarin = 18.7). There was no association between CYP2C9*2 and*3 and acenocoumarol or warfarin requirements. Conclusions: There is an association between VKORC1-1639A variant and anticoagulant doses.


Assuntos
Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Anticoagulantes/administração & dosagem , /genética , Polimorfismo Genético/genética , Vitamina K Epóxido Redutases/genética , Acenocumarol/administração & dosagem , Administração Oral , Chile , Relação Dose-Resposta a Droga , Frequência do Gene/genética , Variação Genética/genética , Genótipo , Coeficiente Internacional Normatizado , Estudos Prospectivos , Tempo de Protrombina , Varfarina/administração & dosagem
12.
Rev. chil. cardiol ; 34(2): 134-139, 2015. graf, tab
Artigo em Espanhol | LILACS | ID: lil-762615

RESUMO

Antecedentes: El monitoreo del tratamiento con anticoagulantes cumarínicos se realiza a través del INR (International Normalized Ratio) que es el parámetro estandarizado del Tiempo de Protrombina. Las recomendaciones de la OMS indican que la precisión en el cálculo del INR puede ser mejorada usando reactivo de tromboplastina con Indice de Sensibilidad Internacional (ISI) bajo, considerándose como ISI de referencia internacional el valor 1,0. Debido a incongruencias observadas en los INR de pacientes controlados en el Servicio de Salud Metropolitano Occidente, comparando valores de muestra venosa con resultados de INR capilar obtenidos en el mismo paciente el mismo día y hora (con reactivos Tromboplastina de distinto ISI), se efectuó un ensayo clínico cruzado entre los distintos métodos. Materiales y métodos: En 100 pacientes se comparó INR venoso con dos tromboplastinas de diferente ISI (1,3 y 1,0) vs aquel efectuado con muestra capilar (ISI 1,0). Resultados: Los resultados del estudio muestran que a partir de valores de INR 3,0 las determinaciones obtenidas usando Tromboplastina de cerebro de conejo ISI=1,3 subestiman el valor de INR para un mismo paciente y una misma muestra. Conclusiones: El uso de Tromboplastina recombinante humana ISI 1,0 permite evitar la subestimación del INR en pacientes con mayor riesgo tromboembóli-co (indicación de INR objetivo más alto). Por ello, este método se adoptó en el control del TACO en pacientes controlados en el Servicio de Salud Occidente.


Background: INR (International Normalized Ratio) is the standard Prothrombin Time parameter for monitoring anticoagulant treatment with coumarin derivatives Recommendations of WHO indicate that precision in the calculation of the INR can be improved using thromboplastins with a low Index of International Sensibility (ISI=1,0). Discrepancies in INR obtained using either this technique or conventional rabbit brain derived reagents in the same sample in patients attending the Servicio de Salud Metropolitano Occidente (West Metropolitan Health Service) were observed. Our objective was to evaluate these discrepancies in a systematic way. Materials and methods: A comparative study was conducted using two thromboplastins of different ISI (1.0 and 1.3) for the calculation of venous INR in comparison with capillary INR in 100 patients. Results: The study showed that INR values may differ significantly according to the method used. In particular, rabbit brain thromboplastin ISI = 1.3 underestimates the value of INR in the range of INR ≥3.0. Conclusions: The use of human recombinant thromboplastin ISI= 1.0. for determination of INR may significantly decrease the risk of hemorrhagic complications in patients requiring higher levels of anticoagulation.


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Coagulação Sanguínea/efeitos dos fármacos , Tromboplastina/administração & dosagem , Tromboplastina/normas , Acenocumarol/administração & dosagem , Tempo de Protrombina , Hemostáticos/administração & dosagem , Administração Oral , Coeficiente Internacional Normatizado , Anticoagulantes
13.
Rev. méd. Chile ; 142(9): 1200-1204, set. 2014. ilus
Artigo em Espanhol | LILACS | ID: lil-730291

RESUMO

The origin of 20% of ischemic strokes is a left ventricular thrombus. We report two patients with strokes originating from cardiac thrombi, treated in two different ways. A 42-year-old diabetic man admitted with a left parietal and occipital stroke. An echocardiogram showed a left ventricular thrombus. The patient was subjected to a surgical cardiac revascularization procedure and left ventricular thrombectomy. The postoperative evolution was uneventful and the patient was discharged on oral anticoagulation. On ambulatory follow up, no neurological deterioration was evidenced. A 38-year-old male admitted with an acute ischemic stroke, was subjected to thrombolysis with human plasminogen activator. An echocardiogram showed a left ventricular thrombus, considered the cause of the stroke. The patient was anticoagulated with heparin and discharged ten days after admission with oral anticoagulation. A new echocardiogram performed one month later, did not show the left ventricular thrombus.


Assuntos
Adulto , Humanos , Masculino , Cardiopatias/complicações , Acidente Vascular Cerebral/terapia , Trombose/complicações , Ecocardiografia , Ventrículos do Coração , Acidente Vascular Cerebral/etiologia , Terapia Trombolítica , Tomografia Computadorizada por Raios X , Resultado do Tratamento
14.
Leuk Res ; 38(7): 795-803, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24811390

RESUMO

Delocalized lipophilic cation dequalinium (DQA) selectively accumulates in mitochondria and displays anticancer activity in different malignancies. Our previous studies indicate a DQA-induced cytotoxicity in human acute promyelocytic leukemia NB4 cells by early disturbance in mitochondrial function and oxidative stress. This study shows the ability of DQA to downregulate Raf/MEK/ERK1/2 and PI3K/Akt signaling pathways in NB4 cells which leads to cell death by apoptosis and/or necrosis. Moreover, DQA potentiates the action of specific inhibitors of these pathways. These DQA effects could be mediated by redox regulation of Akt. Our results contribute to a better understanding of the cytotoxic DQA mechanism on leukemia cells and encourage the performance of further studies in combination with other agents such as kinase inhibitors for improving the efficacy of therapies against acute promyelocytic leukemia.


Assuntos
Dequalínio/farmacologia , MAP Quinases Reguladas por Sinal Extracelular/antagonistas & inibidores , Leucemia/tratamento farmacológico , Quinases de Proteína Quinase Ativadas por Mitógeno/antagonistas & inibidores , Inibidores de Fosfoinositídeo-3 Quinase , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Quinases raf/antagonistas & inibidores , Apoptose/efeitos dos fármacos , Regulação para Baixo , MAP Quinases Reguladas por Sinal Extracelular/fisiologia , Glutationa/metabolismo , Humanos , Leucemia/patologia , Quinases de Proteína Quinase Ativadas por Mitógeno/fisiologia , Fosfatidilinositol 3-Quinases/fisiologia , Proteínas Proto-Oncogênicas c-akt/fisiologia , Quinases raf/fisiologia
15.
Leuk Res ; 35(10): 1395-401, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21477862

RESUMO

Dequalinium, an amphiphilic quinolinium derivative, selectively accumulates in mitochondria and displays anticancer activity in cells from different malignancies. Previous studies indicate a differential DQA-induced cytotoxicity in NB4 and K562 human leukemia cells as a consequence of an early disturbance in mitochondrial function. Results in this paper show that DQA induces a concentration-dependent oxidative stress by decreasing GSH level and increasing ROS in a cell type specific way. Inhibitors of the JNK and p38 stress regulated kinases potentiate DQA-induced NB4 cell death suggesting a protective function for these enzymes. K562 cells with relatively high GSH levels remained resistant to DQA action.


Assuntos
Apoptose/efeitos dos fármacos , Dequalínio , Leucemia/tratamento farmacológico , Mitocôndrias/metabolismo , Western Blotting , Linhagem Celular Tumoral , Dequalínio/farmacologia , Sinergismo Farmacológico , Glutationa/análise , Glutationa/biossíntese , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Leucemia/enzimologia , Leucemia/patologia , Mitocôndrias/efeitos dos fármacos , Especificidade de Órgãos , Oxirredução/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Inibidores de Proteínas Quinases/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/análise , Tensoativos/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
16.
Rev. colomb. ortop. traumatol ; 21(4): 241-245, dic. 2007. graf
Artigo em Espanhol | LILACS | ID: lil-619366

RESUMO

La deformidad en valgo del tobillo se asocia a una gran variedad de condiciones clínicas. El tratamiento de la deformidad en valgo del tobillo con hemifisiodesis percutánea es una alternativa para pacientes mayores de cinco años, que se ha utilizado en los últimos cinco años implantando un tornillo percutáneo en el maléolo tibial. Este es un estudio observacional descriptivo tipo serie de casos, realizado entre 1998 y 2005 en pacientes del Instituto de Ortopedia Infantil Roosevelt; fueron tratados 15 pacientes con diagnóstico de deformidad en valgo del tobillo que requirieron manejo quirúrgico mediante la técnica propuesta.


Assuntos
Traumatismos do Tornozelo , Parafusos Ósseos , Epidemiologia Descritiva , Estudos Observacionais como Assunto , Colômbia
17.
Rev. colomb. ortop. traumatol ; 21(3): 160-164, sept. 2007. graf
Artigo em Espanhol | LILACS | ID: lil-619354

RESUMO

Estudio observacional retrospectivo, tipo serie de casos, realizado entre enero de 1999 y enero de 2006 en el Hospital Universitario Clínica San Rafael en 27 pacientes con fracturas inestables diafisiarias y distales extrarticulares de tibia, a quienes se les realizó osteosíntesis percutánea (técnica mínimamente invasiva) con placa convencional. Se evaluaron parámetros como mecanismo de trauma, tipo de fractura, tiempo de consolidación, función obtenida y complicaciones asociadas. De las fracturas, 24 correspondieron a fracturas diafisiarias (19 del tipo 42-A, 5 del tipo 42-B), y 3 casos fueron fracturas distales extraarticulares (43-A). De las 27 fracturas, 25 consolidaron sin procedimientos adicionales. Un caso requirió una osteotomía por deformidad rotacional y angular superior a 10 grados. Un caso requirió extracción de tornillo distal por aflojamiento. No se presentaron infecciones profundas, fatiga o ruptura de material. Los resultados obtenidos demuestran que la osteosíntesis percutánea con placa convencional no bloqueada es un método efectivo en aquellos casos en que el enclavijamiento endomedular ofrezca dificultades técnicas tales como deformidad previa, canal estrecho, dificultad en bloqueo distal por fragmento corto, o cuando no exista disponibilidad del equipo endomedular. El uso de placas con estabilidad angular es promisorio, y puede disminuir aún más las complicaciones por afl ojamiento, especialmente en fracturas en áreas metafisiarias o con conminución extensa. La técnica percutánea empleada ha disminuido notoriamente las complicaciones de la reducción abierta tradicional, tales como dehiscencia de la herida, infección, deformidad, aflojamiento de material y no consolidación.


Assuntos
Fixação Interna de Fraturas , Estudos Observacionais como Assunto , Estudos Retrospectivos , Fraturas da Tíbia , Colômbia
18.
Leuk Res ; 31(7): 969-78, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17250890

RESUMO

Dequalinium (DQA) has been proposed as a selective antitumoral agent due to its preferential accumulation in mitochondria of cancer cells. Our aim was a better understanding of DQA cytotoxicity. DQA-induced NB4 and K562 cell alterations are initiated within the first 30 min of treatment at a high DQA concentration with a mitochondrial membrane depolarization. Cytochrome c release to cytoplasm, superoxide anion overproduction and ATP depletion in NB4 cells induce, 16 h later, apoptosis by a typical caspase-9/caspase-3-dependent intrinsic pathway. K562 cells were more resistant to the DQA effect than NB4 cells, remaining viable for longer time periods.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Dequalínio/farmacologia , Leucemia/patologia , Mitocôndrias/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo , Trifosfato de Adenosina/metabolismo , Caspase 3/metabolismo , Caspase 9/metabolismo , Proliferação de Células/efeitos dos fármacos , Humanos , Células K562/efeitos dos fármacos , Leucemia/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Mitocôndrias/metabolismo , Membranas Mitocondriais/metabolismo , Oxigênio/metabolismo
19.
Leuk Res ; 29(10): 1201-11, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15893819

RESUMO

Dequalinium (DQA) is a delocalized lipophylic cation that selectively targets the mitochondria of carcinoma cells. However, the underlying mechanisms of DQA action are not yet well understood. We have studied the effects of DQA on two different leukemia cell lines: NB4, derived from acute promyelocytic leukemia, and K562, derived from chronic myeloid leukemia. We found that DQA displays differential cytotoxic activity in these cell lines. In NB4 cells, a low DQA concentration (2microM) induces a mixture of apoptosis and necrosis, whereas a high DQA concentration (20microM) induces mainly necrosis. However, K562 cell death was always by necrosis as the cells showed a resistance to apoptosis at all time-periods and DQA concentrations assayed. In both cell lines, the cell death seems to be mediated by alterations of mitochondrial function as evidenced by loss of mitochondrial transmembrane potential, O2*- accumulation and ATP depletion. The current study improves the knowledge on DQA as a novel anticancer agent with a potential application in human acute promyelocytic leukemia chemotherapy.


Assuntos
Anti-Infecciosos Locais/farmacologia , Apoptose/efeitos dos fármacos , Dequalínio/farmacologia , Leucemia Promielocítica Aguda/tratamento farmacológico , Mitocôndrias/efeitos dos fármacos , Necrose , Trifosfato de Adenosina/metabolismo , Proliferação de Células/efeitos dos fármacos , Humanos , Células K562 , Potenciais da Membrana/efeitos dos fármacos , Mitocôndrias/metabolismo , Oxigênio/metabolismo , Superóxidos/metabolismo , Células Tumorais Cultivadas
20.
Cienc. Trab ; 6(11): 37-38, ene.-mar. 2004. ilus
Artigo em Espanhol | LILACS | ID: lil-386855

RESUMO

Se presenta el primer caso de queratitis fúngica debido a Chrysosporium spp, diagnosticado en Chile. Hifas hialinas fueron detectadas en el raspado corneal y los cultivos fueron positivos a este hongo. el paciente habría sido curado después de tratamiento con Ketoconazol y Natamicina.Las Queratitis causadas por hongos filamentosos, del tipo Especies de Fusarium, Aspergillus inducidos por traumatismos por vegetales, metales y lentes de contacto. En este caso la queratitis se produjo como consecuencia de un traumatismo corneal.


Assuntos
Humanos , Adulto , Chrysosporium , Ceratite , Úlcera da Córnea/complicações , Úlcera da Córnea/diagnóstico , Úlcera da Córnea/terapia , Acidentes de Trabalho , Chile , Cetoconazol , Natamicina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA